Interact to see
Advertisement
Advertisement
HGHRX vs VHCIX
HGHRX vs VHCIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
HGHRX vs. VHCIX commentary
Aug 18, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a Buy and VHCIX is a Buy.
FUNDAMENTALS
Fundamentals
VHCIX has more cash in the bank: 17B vs. HGHRX (755M). VHCIX pays higher dividends than HGHRX: VHCIX (1.65) vs HGHRX (0.00). HGHRX was incepted earlier than VHCIX: HGHRX (19 years) vs VHCIX (22 years). HGHRX (1.63) is less costly to investors than VHCIX (0.09). HGHRX is a more actively managed with annual turnover of: 40.00 vs. VHCIX (4.00). HGHRX has a lower initial minimum investment than VHCIX: HGHRX (0) vs VHCIX (100000). VHCIX annual gain was more profitable for investors over the last year : -9.58 vs. HGHRX (-20.13). VHCIX return over 5 years is better than : 23.54 vs. HGHRX (-20.74).
| HGHRX | VHCIX | HGHRX / VHCIX | |
| Total Expense Ratio | 1.63 | 0.09 | 1,811% |
| Annual Report Gross Expense Ratio | 1.63 | 0.09 | 1,811% |
| Fund Existence | 19 years | 22 years | - |
| Gain YTD | -5.079 | -0.269 | 1,890% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 100000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 755M | 17B | 4% |
| Annual Yield % from dividends | 0.00 | 1.65 | - |
| Returns for 1 year | -20.13 | -9.58 | 210% |
| Returns for 3 years | -8.69 | 1.50 | -580% |
| Returns for 5 years | -20.74 | 23.54 | -88% |
| Returns for 10 years | -21.77 | 77.75 | -28% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement